Two Sigma Investments
IBO

Two Sigma Investments’s Impact BioMedical IBO Stock Holding History

Two Sigma Investments’s Portfolio IBO Stock Details IBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.5K Sell
37,427
-2,400
-6% -$1.2K ﹤0.01% 4505
2025
Q4 		$20.1K Buy
39,827
+8,327
+26% +$4.41K ﹤0.01% 3999
2025
Q3 		$20.9K Buy
31,500
+8,800
+39% +$5.55K ﹤0.01% 3597
2025
Q2 		$14.7K Buy
+22,700
New +$12.7K ﹤0.01% 3133

Other funds holding IBO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM
MAC
Mason & Associates (California) Los Angeles, California $619M AUM 29.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments's IBO Position: Q1 2026 in Review

Two Sigma Investments reduced its Impact BioMedical (IBO) stake by 6% in Q1 2026, selling an estimated $1.2K and leaving 37,427 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4505.

Two Sigma Investments first reported a position in IBO in Q2 2025 and has held it in 4 quarters since. 20 funds tracked by Wall St. Rank hold IBO as of Q1 2026.

  • Two Sigma Investments held 37,427 shares of Impact BioMedical worth $22.5K as of Q1 2026.
  • Two Sigma Investments sold 2,400 Impact BioMedical shares in Q1 2026, an estimated $1.2K.
  • Impact BioMedical made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4505 holding.
  • Two Sigma Investments first reported a position in Impact BioMedical in Q2 2025 and has held it in 4 quarters since.
  • 20 funds tracked by Wall St. Rank held Impact BioMedical as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.